Enilconazole (also known as imazalil) has low acute toxicity but has raised concerns regarding potential carcinogenicity based on older studies. In 1999, based on studies in rodents, enilconazole was identified as "likely to be
carcinogenic in humans" under The
United States Environmental Protection Agency's Draft Guidelines for Carcinogenic Assessment. The EPA determined there is no substantial risk of enilconazole toxicity through food and water exposure. Enilconazole has a very minute degree of mobility, so its level of drinking water contamination is quite low. The estimated environmental concentration (EEC) found the levels to be 0.072
ppb for surface water, which is much less than the 500 ppb comparison level for drinking water. ==References==